Yan Chen, Fischer John P, Freedman Gary M, Basta Marten N, Kovach Stephen J, Serletti Joseph M, Lin Lilie, Wu Liza C
Division of Plastic Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Division of Radiation Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Breast J. 2016 May;22(3):322-9. doi: 10.1111/tbj.12572. Epub 2016 Feb 11.
Certain patients who initiate expander/implant (E/I) reconstruction following mastectomy may require radiation therapy (XRT). XRT may be delivered during the tissue expander (TE) expansion process or after exchange for a permanent implant (PI). We studied a series of women treated with E/I reconstruction and XRT to determine whether there is a difference in complication rates between those who had XRT to the TE versus PI. All two-stage E/I reconstructions at our institution from April 2005 to January 2013 were reviewed to identify patients who underwent XRT after TE placement. Our database was queried for reconstructive details, oncologic treatment, and complications. Statistical analyses were performed to establish significance of complication rate differences. Fifty-two patients underwent XRT after TE placement, 42 of which had XRT to the TE and 11 of which had XRT to the PI. The major complication rates (complications requiring emergent reoperation/readmission) were 27% versus 0% (p = 0.05) for XRT to the TE versus XRT to the PI, but there were no significant differences in minor complication rates (outpatient complications). Specifically, the rates of Grade 3/4 capsular contracture were similar between the two groups, 27% for the XRT to the TE group and 36% for the XRT to the PI group. Radiation of the PI versus radiation of the TE did not result in significant differences in overall surgical complication rates but had fewer major complications and no implant failures. Other factors must also be considered, such as patient preference, risk of cancer reoccurrence, and cosmesis. It is essential for a patient to have a team of a plastic surgeon and radiation, surgical, and medical oncologists working together to achieve each patient's goals.
某些在乳房切除术后开始进行扩张器/植入物(E/I)重建的患者可能需要放射治疗(XRT)。XRT可在组织扩张器(TE)扩张过程中进行,或在更换为永久性植入物(PI)后进行。我们研究了一系列接受E/I重建和XRT治疗的女性,以确定在TE接受XRT与PI接受XRT的患者之间并发症发生率是否存在差异。对我们机构2005年4月至2013年1月期间所有两阶段E/I重建病例进行回顾,以确定在TE植入后接受XRT的患者。查询我们的数据库以获取重建细节、肿瘤治疗情况和并发症信息。进行统计分析以确定并发症发生率差异的显著性。52例患者在TE植入后接受了XRT,其中42例对TE进行了XRT,11例对PI进行了XRT。TE接受XRT与PI接受XRT的主要并发症发生率(需要紧急再次手术/再次入院的并发症)分别为27%和0%(p = 0.05),但次要并发症发生率(门诊并发症)无显著差异。具体而言,两组3/4级包膜挛缩率相似,TE接受XRT组为27%,PI接受XRT组为36%。PI接受放疗与TE接受放疗在总体手术并发症发生率上无显著差异,但主要并发症较少且无植入物失败情况。还必须考虑其他因素,如患者偏好、癌症复发风险和美容效果。患者必须有一个由整形外科医生以及放疗、外科和医学肿瘤学家组成的团队共同协作,以实现每个患者的目标。